Company / Assets per Share
Sana Biotechnology, Inc. Assets per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.17
FY2024
5-year range
$2.17 / $56.12
FY2020-FY2024
Trend
-25.3%
vs FY2023
Sector context
#187 of 210
Health Care
What the data says
Sana Biotechnology, Inc.'s assets per share of $2.17 is lower than 89% of companies in the Health Care sector (FY2024). Assets per Share has declined for 4 consecutive years, from $56.12 in FY2020 to $2.17 in FY2024.
Based on SEC 10-K filings.
2.17 in FY2024 with a 3-year CAGR of -31.6%.
Declined from $4.37 to $2.17 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -31.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 210This company $2.17 Sector average $353.15
▼
-99.4% below sector average
Key checks
Key Insights
- Sana Biotechnology, Inc.'s assets per share has declined for 4 consecutive years.
- In FY2024, assets per share decreased 25.3% year-over-year.
- Ranks #187 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.17 | -25.3% |
| FY2023 | $2.91 | -33.5% |
| FY2022 | $4.37 | -35.6% |
| FY2021 | $6.79 | -87.9% |
| FY2020 | $56.12 | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026